Biocon Limited (NSE: BIOCON)
India
· Delayed Price · Currency is INR 324.60
-2.45 (-0.75%)
Nov 21, 2024, 11:19 AM IST
Biocon Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Revenue | 148,941 | 147,557 | 111,742 | 81,840 | 71,431 | 63,005 | Upgrade
|
| Revenue Growth (YoY) | 9.52% | 32.05% | 36.54% | 14.57% | 13.37% | 14.26% | Upgrade
|
| Cost of Revenue | 56,109 | 55,822 | 42,125 | 31,729 | 22,437 | 23,170 | Upgrade
|
| Gross Profit | 92,832 | 91,735 | 69,617 | 50,111 | 48,994 | 39,835 | Upgrade
|
| Selling, General & Admin | 31,947 | 28,514 | 23,321 | 20,531 | 17,468 | 16,544 | Upgrade
|
| Research & Development | -1,515 | -838 | -3,922 | -4,764 | -3,507 | -3,458 | Upgrade
|
| Other Operating Expenses | 30,064 | 30,526 | 23,434 | 14,611 | 18,326 | 10,706 | Upgrade
|
| Operating Expenses | 76,975 | 73,901 | 53,974 | 38,528 | 39,455 | 29,315 | Upgrade
|
| Operating Income | 15,857 | 17,834 | 15,643 | 11,583 | 9,539 | 10,520 | Upgrade
|
| Interest Expense | -9,553 | -9,744 | -4,190 | -676 | -577 | -649 | Upgrade
|
| Interest & Investment Income | 1,613 | 1,613 | 1,124 | 1,121 | 770 | 824 | Upgrade
|
| Earnings From Equity Investments | -268 | -842 | -1,670 | -2,069 | -794 | - | Upgrade
|
| Currency Exchange Gain (Loss) | -523 | -523 | -1,605 | 579 | -89 | 653 | Upgrade
|
| Other Non Operating Income (Expenses) | 3,312 | 4,288 | 39 | 7 | 94 | 50 | Upgrade
|
| EBT Excluding Unusual Items | 10,438 | 12,626 | 9,341 | 10,545 | 8,943 | 11,398 | Upgrade
|
| Merger & Restructuring Charges | - | - | -470 | - | - | -38 | Upgrade
|
| Gain (Loss) on Sale of Investments | 2,008 | 2,754 | 2,596 | 420 | 84 | 87 | Upgrade
|
| Gain (Loss) on Sale of Assets | 10,561 | -12 | -52 | -23 | 1,524 | -11 | Upgrade
|
| Asset Writedown | -3,945 | -3,945 | - | - | - | - | Upgrade
|
| Other Unusual Items | 4,649 | 3,829 | -2,444 | -1,111 | -224 | - | Upgrade
|
| Pretax Income | 23,711 | 15,252 | 8,971 | 9,831 | 10,677 | 12,149 | Upgrade
|
| Income Tax Expense | 5,060 | 2,274 | 2,541 | 2,115 | 2,215 | 3,151 | Upgrade
|
| Earnings From Continuing Operations | 18,651 | 12,978 | 6,430 | 7,716 | 8,462 | 8,998 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | - | - | -289 | Upgrade
|
| Net Income to Company | 18,651 | 12,978 | 6,430 | 7,716 | 8,462 | 8,709 | Upgrade
|
| Minority Interest in Earnings | -4,259 | -2,753 | -1,803 | -1,232 | -1,057 | -1,227 | Upgrade
|
| Net Income | 14,392 | 10,225 | 4,627 | 6,484 | 7,405 | 7,482 | Upgrade
|
| Net Income to Common | 14,392 | 10,225 | 4,627 | 6,484 | 7,405 | 7,482 | Upgrade
|
| Net Income Growth | 188.76% | 120.99% | -28.64% | -12.44% | -1.03% | -17.35% | Upgrade
|
| Shares Outstanding (Basic) | 1,196 | 1,195 | 1,193 | 1,191 | 1,187 | 1,184 | Upgrade
|
| Shares Outstanding (Diluted) | 1,199 | 1,197 | 1,196 | 1,196 | 1,197 | 1,187 | Upgrade
|
| Shares Change (YoY) | 0.28% | 0.08% | -0.04% | -0.03% | 0.80% | -0.32% | Upgrade
|
| EPS (Basic) | 12.03 | 8.55 | 3.88 | 5.44 | 6.24 | 6.32 | Upgrade
|
| EPS (Diluted) | 12.00 | 8.54 | 3.87 | 5.42 | 6.19 | 6.30 | Upgrade
|
| EPS Growth | 187.81% | 120.67% | -28.60% | -12.44% | -1.69% | -17.15% | Upgrade
|
| Free Cash Flow | 23,996 | 12,734 | 2,565 | -5,212 | -3,572 | -3,211 | Upgrade
|
| Free Cash Flow Per Share | 20.02 | 10.64 | 2.14 | -4.36 | -2.98 | -2.70 | Upgrade
|
| Dividend Per Share | - | 0.500 | 1.500 | 0.500 | - | - | Upgrade
|
| Dividend Growth | - | -66.67% | 200.00% | - | - | - | Upgrade
|
| Gross Margin | 62.33% | 62.17% | 62.30% | 61.23% | 68.59% | 63.23% | Upgrade
|
| Operating Margin | 10.65% | 12.09% | 14.00% | 14.15% | 13.35% | 16.70% | Upgrade
|
| Profit Margin | 9.66% | 6.93% | 4.14% | 7.92% | 10.37% | 11.88% | Upgrade
|
| Free Cash Flow Margin | 16.11% | 8.63% | 2.30% | -6.37% | -5.00% | -5.10% | Upgrade
|
| EBITDA | 31,861 | 33,058 | 26,567 | 19,564 | 16,522 | 15,944 | Upgrade
|
| EBITDA Margin | 21.39% | 22.40% | 23.78% | 23.91% | 23.13% | 25.31% | Upgrade
|
| D&A For EBITDA | 16,004 | 15,224 | 10,924 | 7,981 | 6,983 | 5,424 | Upgrade
|
| EBIT | 15,857 | 17,834 | 15,643 | 11,583 | 9,539 | 10,520 | Upgrade
|
| EBIT Margin | 10.65% | 12.09% | 14.00% | 14.15% | 13.35% | 16.70% | Upgrade
|
| Effective Tax Rate | 21.34% | 14.91% | 28.32% | 21.51% | 20.75% | 25.94% | Upgrade
|
| Revenue as Reported | 166,447 | 156,212 | 115,501 | 83,967 | 73,976 | 64,619 | Upgrade
|
| Advertising Expenses | - | 1,870 | 1,482 | 1,692 | - | 1,951 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.